It seems fair enough to talk about SENS in connection with a long awaited research success that is in the SENS portfolio, and has been since the beginning. htt

It seems fair enough to talk about SENS in connection with a long awaited research success that is in the SENS portfolio, and has been since the beginning. http://sens.org/research/introduction-to-sens-research/deathresistant-cells http://sens.org/research/introduction-to-sens-research/death... The SENS Research Foundation has for some years funded work on clearing senescent cells at the Campisi lab, and Judith Campisi is one of the people involved in Union Biotechnology, the company commercializing therapies created from the study discussed here. Senescent cell clearance was advocated and funded by SENS advocates and organizations long before the rest of the scientific community caught up. It has been a long slog to get to the tipping point, and here we are, being proved right. So, you know, slightly relevant.